Additionally, a methylation study of liver cancer indicated that low expression of IL-6 can reduce angiogenesis in HCC tissues (81), suggesting that the IL-6/STAT3 signaling pathway can promote angiogenesis in tumor tissues and provide nutrient guarantees for the development of tumorigenesis. Here, STAT3 is linked to liver cancer.